Go to
JCI Insight
About
Editors
Consulting Editors
For authors
Publication ethics
Alerts
Advertising
Job board
Subscribe
Contact
Current issue
Past issues
By specialty
COVID-19
Cardiology
Gastroenterology
Immunology
Metabolism
Nephrology
Neuroscience
Oncology
Pulmonology
Vascular biology
All ...
Videos
Conversations with Giants in Medicine
Author's Takes
Reviews
Reviews
View all reviews ...
Review Series
Next-Generation Sequencing in Medicine (Upcoming)
New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
Immunometabolism (Jan 2022)
Circadian Rhythm (Oct 2021)
Gut-Brain Axis (Jul 2021)
Tumor Microenvironment (Mar 2021)
100th Anniversary of Insulin's Discovery (Jan 2021)
View all review series ...
Viewpoint
Collections
In-Press Preview
Commentaries
Concise Communication
Editorials
Viewpoint
Top read articles
Clinical Medicine
JCI This Month
Current issue
Past issues
Targeted disruption of H3 receptors results in changes in brain histamine tone leading to an obese phenotype
Kazuhiko Takahashi, … , Tomoo Ishikawa, Hidehito Kotani
Kazuhiko Takahashi, … , Tomoo Ishikawa, Hidehito Kotani
Published December 15, 2002
Citation Information:
J Clin Invest.
2002;
110(12)
:1791-1799.
https://doi.org/10.1172/JCI15784
.
View:
Text
|
PDF
Article
Metabolism
Targeted disruption of H3 receptors results in changes in brain histamine tone leading to an obese phenotype
Text
PDF
Abstract
Research Article
Authors
Kazuhiko Takahashi, Hiroaki Suwa, Tomoo Ishikawa, Hidehito Kotani
×
Full Text PDF |
Download
(636.73 KB)
